Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Merck KGaA

Capitalization 48.26B 55.85B 43.57B 41.67B 75.95B 5,150B 78.09B 515B 205B 2,463B 210B 205B 8,870B P/E ratio 2026 *
17.4x
P/E ratio 2027 * 14.9x
Enterprise value 55.23B 63.92B 49.87B 47.69B 86.93B 5,895B 89.37B 589B 235B 2,819B 240B 235B 10,152B EV / Sales 2026 *
2.62x
EV / Sales 2027 * 2.37x
Free-Float
29.72%
Yield 2026 *
2.14%
Yield 2027 * 2.24%
1 day-0.09%
1 week-2.12%
Current month-13.64%
1 month-11.64%
3 months-5.98%
6 months+3.79%
Current year-9.62%
1 week 106.65
Extreme 106.65
114.55
1 month 106.65
Extreme 106.65
129.3
Current year 106.65
Extreme 106.65
131.65
1 year 100.7
Extreme 100.7
137.45
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 71.15
Extreme 71.15
231.5
Manager TitleAgeSince
Chief Executive Officer 64 30/04/2021
Director of Finance/CFO 55 30/06/2023
Chief Tech/Sci/R&D Officer - 30/06/2021
Director TitleAgeSince
Director/Board Member - 25/04/2019
Director/Board Member 63 30/04/2012
Director/Board Member 77 08/05/2014
Change 5d. change 1-year change 3-years change Capi.($)
-0.09%-2.12%-17.47%-34.77% 55.85B
-1.96%-5.06%+8.19%+59.69% 7.85B
+0.26%+6.42%+4.63%-18.97% 7.57B
-1.20%+1.23%-6.09%+58.17% 5.23B
0.00%+6.60%-17.85%+100.44% 4.96B
-0.84%-4.25%+66.21%+52.19% 3.06B
-1.15%+5.09%-13.60%-18.45% 2.69B
+3.29%+1.62%+43.40%+44.49% 2.59B
-6.67%+3.98%+321.37%+563.91% 2.47B
-0.09%+3.50%-3.45%+7.47% 2.13B
Average -0.84%-1.93%+38.53%+81.42% 9.44B
Weighted average by Cap. -0.41%-6.42%+0.74%+8.70%

Financials

2026 *2027 *
Net sales 21.05B 24.36B 19B 18.18B 33.13B 2,247B 34.06B 225B 89.55B 1,074B 91.41B 89.48B 3,869B 22.05B 25.52B 19.91B 19.04B 34.71B 2,354B 35.68B 235B 93.81B 1,125B 95.76B 93.75B 4,053B
Net income 2.7B 3.12B 2.44B 2.33B 4.25B 288B 4.36B 28.79B 11.48B 138B 11.71B 11.47B 496B 3.16B 3.66B 2.85B 2.73B 4.98B 337B 5.12B 33.75B 13.45B 161B 13.73B 13.44B 581B
Net Debt 6.97B 8.07B 6.3B 6.02B 10.98B 744B 11.28B 74.42B 29.67B 356B 30.28B 29.64B 1,282B 4.11B 4.76B 3.71B 3.55B 6.47B 439B 6.65B 43.89B 17.49B 210B 17.86B 17.48B 756B
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
59,077
Date Price Change Volume
12/03/26 110.75 -0.23% 52,026
11/03/26 111.00 0.00% 408,708
10/03/26 111.00 +3.11% 436,170
09/03/26 107.65 -2.27% 496,716
06/03/26 110.15 -2.69% 737,000
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
111.00EUR
Average target price
149.00EUR
Spread / Average Target
+34.23%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW